US › Healthcare

Envoy Medical Inc. (COCH)

US · Healthcare · Medical Devices

$0.69-0.35%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$39,000
Revenue YoY
-15.2%
Net profit
$-4.4M
Profit YoY
+12.9%
EPS
$-0.32
EPS estimate
$-0.09
Net margin
-11,156.4%

EPS came in at -0.32 against a street estimate of -0.09 — a miss of 255.6%.

Key statistics

Market cap
$51.7M
Forward P/E
0.0
P/B
4.96
Book value
$0.14
EPS (TTM)
$-1.02
52-week high
$1.89
52-week low
$0.36
50-day MA
$0.69
200-day MA
$0.71
Beta
1.86

Analyst view

Analysts rate Envoy Medical Inc. a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $2.25.

Shareholding

Insiders
40.50%
Institutions
22.86%

Largest institutional holders

FundStake
Nantahala Capital Management, LLC9.93%
Bleichroeder LP8.11%
Vanguard Capital Management, LLC1.14%
Geode Capital Management, LLC0.68%
Vanguard Fiduciary Trust Co0.38%
The Colony Group LLC0.28%
Arcus Capital Partners LLC0.24%
Northern Trust Corp0.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Envoy Medical Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.